Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation
Hee-Seon Park, Jiwon Song, Jinho Park, et al.
Autophagy (2020) Vol. 17, Iss. 9, pp. 2549-2564
Open Access | Times Cited: 152

Showing 1-25 of 152 citing articles:

Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)
Xiaohan Xu, Kyle L. Poulsen, Lijuan Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 207
Inflammation‐mediated metabolic regulation in adipose tissue
Shujie Xu, Feng Lu, Jianhua Gao, et al.
Obesity Reviews (2024) Vol. 25, Iss. 6
Closed Access | Times Cited: 17
The protective effect of selenoprotein M on non-alcoholic fatty liver disease: the role of the AMPKα1–MFN2 pathway and Parkin mitophagy
Jingzeng Cai, Jiaqiang Huang, Jie Yang, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 7
Closed Access | Times Cited: 63
Fusobacterium nucleatum Promotes Colorectal Cancer Cell to Acquire Stem Cell‐Like Features by Manipulating Lipid Droplet‐Mediated Numb Degradation
Haiyang Liu, Junfeng Du, Shanshan Chao, et al.
Advanced Science (2022) Vol. 9, Iss. 12
Open Access | Times Cited: 56
mTOR: A Potential New Target in Nonalcoholic Fatty Liver Disease
Jiayao Feng, Shuting Qiu, Shipeng Zhou, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9196-9196
Open Access | Times Cited: 53
mTOR in programmed cell death and its therapeutic implications
Yawen Xie, Xianli Lei, Guoyu Zhao, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 71-72, pp. 66-81
Open Access | Times Cited: 36
The double-edged effects of IL-6 in liver regeneration, aging, inflammation, and diseases
Minjun Wang, Hailing Zhang, Fei Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Hepatic Zbtb18 (Zinc Finger and BTB Domain Containing 18) alleviates hepatic steatohepatitis via FXR (Farnesoid X Receptor)
Lei Zhang, Jiabing Chen, Xiaoying Yang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disease in mice
Zhaowei Zou, Xiu Liu, Jie Yu, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 6, pp. 834-845
Closed Access | Times Cited: 9
Proteostasis disruption and senescence in Alzheimer’s disease pathways to neurodegeneration
Riya Thapa, Asif Ahmad Bhat, Moyad Shahwan, et al.
Brain Research (2024) Vol. 1845, pp. 149202-149202
Closed Access | Times Cited: 9
Beyond Redox Regulation: Novel Roles of TXNIP in the Pathogenesis and Therapeutic Targeting of Kidney Disease
Chuang Li, Yili Fang, Ying Maggie Chen
American Journal Of Pathology (2025)
Closed Access | Times Cited: 1
Prophylactic effects of nutrition, dietary strategies, exercise, lifestyle and environment on nonalcoholic fatty liver disease
Xiangyong Hao, Hao Song, Xin Su, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access | Times Cited: 1
Hypomethylation induced overexpression of PLOD3 facilitates colorectal cancer progression through TM9SF4-mediated autophagy
Renzhong Zhu, Chen Tian, Ningning Gao, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Aurantio-Obtusin Attenuates Non-Alcoholic Fatty Liver Disease Through AMPK-Mediated Autophagy and Fatty Acid Oxidation Pathways
Fei Zhou, Mingning Ding, Yiqing Gu, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 34
The Role of Autophagy and Pyroptosis in Liver Disorders
Huijie Zhao, Huiyang Liu, Yihan Yang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6208-6208
Open Access | Times Cited: 33
TXNIP Suppresses the Osteochondrogenic Switch of Vascular Smooth Muscle Cells in Atherosclerosis
Sang‐Ho Woo, Dong Soo Kyung, Seung Hyun Lee, et al.
Circulation Research (2022) Vol. 132, Iss. 1, pp. 52-71
Open Access | Times Cited: 32
Metabolic Role of Autophagy in the Pathogenesis and Development of NAFLD
Lingxuan An, Ulrich Wirth, Dominik Koch, et al.
Metabolites (2023) Vol. 13, Iss. 1, pp. 101-101
Open Access | Times Cited: 19
Oleic acid improves hepatic lipotoxicity injury by alleviating autophagy dysfunction
Xiaohong Liu, Xiaoyu Li, Shan Su, et al.
Experimental Cell Research (2023) Vol. 429, Iss. 2, pp. 113655-113655
Closed Access | Times Cited: 17
TXNIP in liver sinusoidal endothelial cells ameliorates alcohol-associated liver disease via nitric oxide production
Eun‐Hye Jung, Eun Bok Baek, Eun-Ju Hong, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 2, pp. 606-620
Open Access | Times Cited: 8
Targeted inhibition of autophagy in hepatic stellate cells by hydroxychloroquine: An effective therapeutic approach for the treatment of liver fibrosis
Li‐Shuang Hou, Xiao‐Pei Zhai, Yao‐Wen Zhang, et al.
Liver International (2024) Vol. 44, Iss. 8, pp. 1937-1951
Closed Access | Times Cited: 7
A Systematic Review of Proteomics in Obesity: Unpacking the Molecular Puzzle
Alba Rodríguez-Muñoz, Hanieh Motahari-Rad, Laura Martin-Chaves, et al.
Current Obesity Reports (2024) Vol. 13, Iss. 3, pp. 403-438
Open Access | Times Cited: 7
Punicalagin Ameliorates Diabetic Liver Injury by Inhibiting Pyroptosis and Promoting Autophagy via Modulation of the FoxO1/TXNIP Signaling Pathway
Xiuying Tan, Long Yi, Rou Zhang, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 12
Closed Access | Times Cited: 7
Lipid Nanoparticle‐Mediated Delivery of CRISPR‐Cas9 Against Rubicon Ameliorates NAFLD by Modulating CD36 Along with Glycerophospholipid Metabolism
Yu Bai, Yanyang Nan, Tao Wu, et al.
Advanced Science (2024) Vol. 11, Iss. 31
Open Access | Times Cited: 7
Multi-omics joint analysis reveals that the Miao medicine Yindanxinnaotong formula attenuates non-alcoholic fatty liver disease
Lei Huang, Qing Rao, Chaoyan Wang, et al.
Phytomedicine (2024) Vol. 135, pp. 156026-156026
Closed Access | Times Cited: 7
Evidence for Lysosomal Dysfunction within the Epidermis in Psoriasis and Atopic Dermatitis
Kim Klapan, Živa Frangež, Nikita Markov, et al.
Journal of Investigative Dermatology (2021) Vol. 141, Iss. 12, pp. 2838-2848.e4
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top